Total Payments
$1,013
2024 Payments
$478.48
Companies
10
Transactions
48
Medicare Patients
1,204
Medicare Billing
$257,626
Payment Breakdown by Category
Food & Beverage$1,013 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,013 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $492.26 | 7 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $293.38 | 26 | $0 (2020) |
| UCB, Inc. | $58.23 | 4 | $0 (2019) |
| Eisai Inc. | $51.09 | 3 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $30.92 | 2 | $0 (2021) |
| Aprecia Pharmaceuticals, LLC | $29.29 | 2 | $0 (2020) |
| LivaNova USA, Inc. | $17.50 | 1 | $0 (2019) |
| AQUESTIVE THERAPEUTICS, INC. | $15.06 | 1 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $12.79 | 1 | $0 (2019) |
| Merz North America, Inc. | $12.69 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.48 | 6 | SK Life Science, Inc. ($478.48) |
| 2021 | $68.28 | 4 | Eisai Inc. ($37.36) |
| 2020 | $195.27 | 18 | Supernus Pharmaceuticals, Inc. ($153.20) |
| 2019 | $271.18 | 20 | Supernus Pharmaceuticals, Inc. ($140.18) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $140.35 | General |
| Category: Neurology | ||||||
| 12/09/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $107.30 | General |
| 12/09/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $37.55 | General |
| 12/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $23.32 | General |
| 08/07/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.27 | General |
| 07/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $148.69 | General |
| 09/08/2021 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: CNS | ||||||
| 09/07/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $13.65 | General |
| Category: Neurology | ||||||
| 07/14/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $23.71 | General |
| Category: Neurology | ||||||
| 04/06/2021 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: CNS | ||||||
| 11/13/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: AED | ||||||
| 11/06/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.62 | General |
| Category: AED | ||||||
| 10/22/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $7.31 | General |
| Category: AED | ||||||
| 10/09/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $6.63 | General |
| Category: AED | ||||||
| 09/29/2020 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $13.73 | General |
| Category: Neurology | ||||||
| 09/18/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.80 | General |
| Category: AED | ||||||
| 08/28/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $6.57 | General |
| Category: AED | ||||||
| 08/27/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $7.53 | General |
| Category: AED | ||||||
| 08/19/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $4.60 | General |
| Category: AED | ||||||
| 08/18/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $5.91 | General |
| Category: AED | ||||||
| 08/06/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $9.54 | General |
| Category: AED | ||||||
| 08/01/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| Category: AED | ||||||
| 07/28/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $9.82 | General |
| Category: AED | ||||||
| 06/01/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.37 | General |
| Category: AED | ||||||
| 02/25/2020 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $13.78 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 75 | 102 | $70,964 | $11,158 |
| 2022 | 4 | 67 | 95 | $73,533 | $11,852 |
| 2021 | 6 | 539 | 854 | $1.5M | $111,700 |
| 2020 | 6 | 523 | 930 | $380,035 | $122,916 |
Total Patients
1,204
Total Services
1,981
Medicare Billing
$257,626
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 16 | 37 | $38,443 | $5,801 | 15.1% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 17 | 18 | $12,078 | $1,882 | 15.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $7,920 | $1,573 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 19 | $7,372 | $1,191 | 16.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 17 | 17 | $5,151 | $711.52 | 13.8% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 21 | 48 | $49,872 | $7,909 | 15.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $8,640 | $1,609 | 18.6% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 12 | 12 | $8,052 | $1,286 | 16.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 22 | 23 | $6,969 | $1,048 | 15.0% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 211 | 433 | $1.3M | $77,755 | 6.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 94 | 172 | $59,659 | $10,743 | 18.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 79 | 80 | $35,403 | $9,450 | 26.7% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 68 | 69 | $100,803 | $8,058 | 8.0% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 71 | 72 | $36,000 | $3,650 | 10.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 28 | $6,835 | $2,044 | 29.9% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 198 | 473 | $310,083 | $85,979 | 27.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 112 | 237 | $20,533 | $14,934 | 72.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 86 | 88 | $13,662 | $10,583 | 77.5% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 66 | 66 | $30,684 | $7,732 | 25.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 46 | 47 | $3,460 | $2,405 | 69.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 19 | $1,612 | $1,283 | 79.6% |
About Dr. Aaron Geller, MD
Dr. Aaron Geller, MD is a Epilepsy healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2012. The National Provider Identifier (NPI) number assigned to this provider is 1447516828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Geller, MD has received a total of $1,013 in payments from pharmaceutical and medical device companies, with $478.48 received in 2024. These payments were reported across 48 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,013).
As a Medicare-enrolled provider, Geller has provided services to 1,204 Medicare beneficiaries, totaling 1,981 services with total Medicare billing of $257,626. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology, Clinical Neurophysiology
- Location Aurora, CO
- Active Since 04/10/2012
- Last Updated 12/16/2021
- Taxonomy Code 2084E0001X
- Entity Type Individual
- NPI Number 1447516828
Products in Payments
- OXTELLAR XR (Drug) $285.85
- XCOPRI (Drug) $140.35
- Briviact (Drug) $58.23
- Fycompa (Drug) $51.09
- APTIOM (Drug) $30.92
- Spritam (Drug) $29.29
- VNS Therapy (Device) $17.50
- SYMPAZAN (Drug) $15.06
- DYSPORT (Drug) $12.79
- XEOMIN (Biological) $12.69
- TROKENDI XR (Drug) $7.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.